1. Home
  2. PCVX vs ATR Comparison

PCVX vs ATR Comparison

Compare PCVX & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • ATR
  • Stock Information
  • Founded
  • PCVX 2013
  • ATR 1992
  • Country
  • PCVX United States
  • ATR United States
  • Employees
  • PCVX N/A
  • ATR N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • ATR Plastic Products
  • Sector
  • PCVX Health Care
  • ATR Industrials
  • Exchange
  • PCVX Nasdaq
  • ATR Nasdaq
  • Market Cap
  • PCVX 4.5B
  • ATR 9.6B
  • IPO Year
  • PCVX 2020
  • ATR 1993
  • Fundamental
  • Price
  • PCVX $31.16
  • ATR $153.31
  • Analyst Decision
  • PCVX Strong Buy
  • ATR Strong Buy
  • Analyst Count
  • PCVX 10
  • ATR 4
  • Target Price
  • PCVX $136.50
  • ATR $180.00
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • ATR 322.8K
  • Earning Date
  • PCVX 05-07-2025
  • ATR 05-01-2025
  • Dividend Yield
  • PCVX N/A
  • ATR 1.17%
  • EPS Growth
  • PCVX N/A
  • ATR 17.39
  • EPS
  • PCVX N/A
  • ATR 5.47
  • Revenue
  • PCVX N/A
  • ATR $3,554,747,000.00
  • Revenue This Year
  • PCVX N/A
  • ATR $3.02
  • Revenue Next Year
  • PCVX N/A
  • ATR $5.61
  • P/E Ratio
  • PCVX N/A
  • ATR $28.03
  • Revenue Growth
  • PCVX N/A
  • ATR 0.34
  • 52 Week Low
  • PCVX $27.66
  • ATR $130.85
  • 52 Week High
  • PCVX $121.06
  • ATR $178.03
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.73
  • ATR 60.23
  • Support Level
  • PCVX $28.09
  • ATR $149.42
  • Resistance Level
  • PCVX $33.75
  • ATR $154.57
  • Average True Range (ATR)
  • PCVX 2.54
  • ATR 3.34
  • MACD
  • PCVX 1.12
  • ATR 0.59
  • Stochastic Oscillator
  • PCVX 35.61
  • ATR 88.52

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Share on Social Networks: